Andrew Nierenberg, MD holds the Thomas P. Hackett, MD, Endowed Chair in Psychiatry at Massachusetts General and is the Director of the Dauten Family Center for Bipolar Treatment Innovation, Associate Director of the Depression Clinical and Research Program, and Co-Director of Center for Clinical Research Education, Division of Clinical Research at the Mass General Research Institute. Dr. Nierenberg is a professor of psychiatry at Harvard Medical School.
-
While PTSD and bipolar disorder commonly occur together, no specific treatment guidelines exist for this population. -
In patients with severe bipolar depression and suicidality, can the NMDA receptor antagonist D-cycloserine reduce risk of recurrent depression? -
Decades of research has provided clinicians with a consistent knowledge base of how to diagnose and treat adult bipolar patients. Children, though, are a different […] -
Brain organoids are miniature three-dimensional tissue cultures derived from human pluripotent stem cells, offering an in vitro avenue for advancing our understanding of brain development […] -
Like ketamine, xenon modulates glutaminergic neurotransmission and is an antagonist of the NMDA receptor. Does it also have antidepressant effects? -
Patients with bipolar disorder are at high risk for suicide, with estimates suggesting that between 25% and 60% of those with bipolar disorder will attempt […]